Arcturus Therapeutics Holdings (ARCT) Retained Earnings (2018 - 2026)

Arcturus Therapeutics Holdings has reported Retained Earnings for 9 years, with the latest figure at -$541.6 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 17.0% year-over-year to -$541.6 million; the trailing twelve-month figure through Mar 2026 stood at -$541.6 million (down 17.0% YoY), and the FY2025 full-year result was -$514.6 million, down 14.66% from the prior year.
• Retained Earnings for Q1 2026 stood at -$541.6 million, down from -$514.6 million in the prior quarter.
• The five-year high for Retained Earnings was -$287.4 million in Q1 2023, with the low at -$541.6 million in Q1 2026.
• Historically, Retained Earnings has averaged -$418.5 million across 5 years, with a median of -$418.8 million in 2024.
• Annual changes were most pronounced in 2022 — Retained Earnings plunged 99.15% — and 2023, when it gained 27.92%.
• Arcturus Therapeutics Holdings' Retained Earnings stood at -$338.1 million in 2022, then fell by 8.79% to -$367.9 million in 2023, then fell by 22.0% to -$448.8 million in 2024, then retreated by 14.66% to -$514.6 million in 2025, then slipped by 5.24% to -$541.6 million in 2026.
• The last three Retained Earnings figures came in at -$541.6 million (Q1 2026), -$514.6 million (Q4 2025), and -$485.5 million (Q3 2025), per Business Quant data.